Published 19:58 IST, January 19th 2021
Russia's second COVID-19 vaccine EpiVacCorona '100% effective' in early trials: Report
Russia’s 2nd COVID vaccine candidate, EpiVacCorona, has proved to be 100% effective in early-stage trials, consumer health watchdog Rospotrebnadzor reported.
null | Image:
self
- Listen to this article
- 2 min read
Advertisement
19:58 IST, January 19th 2021